Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of parkinson's disease patients
- 1 July 1994
- journal article
- Published by Elsevier in Neuroscience
- Vol. 61 (1) , 73-79
- https://doi.org/10.1016/0306-4522(94)90061-2
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brainBrain Research, 1991
- Localization of neuropeptide receptor mRNA in rat brain: Initial observations using probes for neurotensin and substance P receptorsNeuroscience Letters, 1990
- Neurotensin receptors in parkinson's disease and progressive supranuclear palsy: an autoradiographic study in basal gangliaNeuroscience, 1990
- Effects of repeated treatment with haloperidol on rat striatal neutral endopeptidase, and on μ- and δ-opioid binding sites: Comparison with chronic morphine and chronic kelatorphanNeuroscience Letters, 1989
- Subtraction autoradiography of opiate receptor subtypes in human brainBrain Research, 1987
- Peptides and Parkinson's diseaseTrends in Neurosciences, 1985
- Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's diseaseAnnals of Neurology, 1985
- Evidence for the presynaptic localization of opiate binding sites on striatal efferent fibersBrain Research, 1984
- Loss of Striatal Neurons in Parkinson’s Disease: a Cytometric StudyEuropean Neurology, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976